A Case of Guillain-Barré Syndrome Possibly Associated With COVID-19 Infection

TL;DR

This paper reports a case of Guillain-Barré Syndrome possibly linked to a second infection with the virus that causes COVID-19.

Contribution

The paper presents a confirmed case of GBS following reinfection with SARS-CoV-2, supporting emerging evidence of neurological complications.

Findings

A case of Guillain-Barré Syndrome was confirmed after a patient experienced reinfection with SARS-CoV-2.

This case adds to evidence suggesting a potential link between SARS-CoV-2 reinfection and neurological complications like GBS.

Abstract

Guillain-Barré syndrome (GBS) is a neurological disorder characterized by progressive and symmetric muscle weakness accompanied by the absence or depression of deep tendon reflexes. It is typically associated with a preceding viral infection, such as the Epstein-Barr virus, cytomegalovirus, hepatitis E virus, and Zika virus, or bacterial pathogens like Campylobacter jejuni and Mycoplasma pneumoniae. Recently, rare cases of GBS have been reported following infection with COVID-19, suggesting a potential association between SARS-CoV-2 and GBS. In this report, we present a clinically and diagnostically confirmed case of GBS following COVID-19 reinfection, which supports emerging data on the neurological complications associated with subsequent episodes of infection by the novel coronavirus.

Figures